These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 1264362)

  • 1. [Respiratory tract infections. Updating on the subject of oral antibiotic treatment with cephaloporins].
    Minerva Med; 1976 Mar; 67(13):828-9. PubMed ID: 1264362
    [No Abstract]   [Full Text] [Related]  

  • 2. [Differentiated use of quinolones and cephalosporins].
    Internist (Berl); 1995 Nov; 36(11 Suppl):1-8. PubMed ID: 9131081
    [No Abstract]   [Full Text] [Related]  

  • 3. [Cefditoren pivoxil: A new oral cephalosporin for skin, soft tissue and respiratory tract infections].
    Hernández-Martin J; Romá E; Salavert M; Doménech L; Poveda JL
    Rev Esp Quimioter; 2006 Sep; 19(3):231-46. PubMed ID: 17099791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The efficacy of cefditoren pivoxil in the treatment of lower respiratory tract infections, with a focus on the per-pathogen bacteriologic response in infections caused by Streptococcus pneumoniae and Haemophilus influenzae: a pooled analysis of seven clinical trials.
    Granizo JJ; Giménez MJ; Barberán J; Coronel P; Gimeno M; Aguilar L
    Clin Ther; 2006 Dec; 28(12):2061-9. PubMed ID: 17296462
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Use of oral cephalosporins].
    Kujala P
    Duodecim; 1999; 115(20):2241-7. PubMed ID: 11973928
    [No Abstract]   [Full Text] [Related]  

  • 6. [Evaluation of the use of oral cefatrizine in the treatment of acute bacterial infections of the respiratory tract].
    Cafiero F; Gipponi M; Frassetto GL; Benevolo E; Reboa G; Sala G
    Clin Ter; 1985 Apr; 113(1):29-32. PubMed ID: 4017483
    [No Abstract]   [Full Text] [Related]  

  • 7. [Clinico-therapeutic studies of the use of a new oral antibiotic in medical pathology].
    Corinaldesi R
    Minerva Med; 1973 Apr; 64(26):1385-92. PubMed ID: 4575095
    [No Abstract]   [Full Text] [Related]  

  • 8. Oral cephalosporins: newer agents and their place in therapy.
    Thompson EM; Shaughnessy AF
    Am Fam Physician; 1994 Aug; 50(2):401-5. PubMed ID: 8042575
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Therapeutic efficacy of cefalexin in internal medicine].
    Lechi A; Cecchetin M
    Clin Ter; 1972 Mar; 60(5):439-47. PubMed ID: 5038776
    [No Abstract]   [Full Text] [Related]  

  • 10. [Antibacterial therapy in lower respiratory tract infections].
    Mar Molinero F; Ramos Amador JT; Sánchez Díaz JI
    An Esp Pediatr; 1997 Jun; Spec No 2():207-8. PubMed ID: 9382308
    [No Abstract]   [Full Text] [Related]  

  • 11. Antibiotic prescriptions associated with outpatient visits for acute upper respiratory tract infections among adult Medicaid recipients in North Carolina.
    Brown DW; Taylor R; Rogers A; Weiser R; Kelley M
    N C Med J; 2003; 64(4):148-56. PubMed ID: 12971239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cephalexin--a new oral antibiotic.
    Bailey A; Walker A; Hadley A; James DG
    Practitioner; 1970 Dec; 205(230):791-5. PubMed ID: 5493717
    [No Abstract]   [Full Text] [Related]  

  • 13. [Update on antibiotic therapy. 13) Cefroxadine].
    Di Nola F
    Minerva Med; 1983 Jan; 74(1-2):85-8. PubMed ID: 6823338
    [No Abstract]   [Full Text] [Related]  

  • 14. Cefdinir: an oral cephalosporin for the treatment of respiratory tract infections and skin and skin structure infections.
    Sader HS; Jones RN
    Expert Rev Anti Infect Ther; 2007 Feb; 5(1):29-43. PubMed ID: 17266451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Antibiotic treatment strategies in cystic fibrosis].
    Smaczny C
    Pneumologie; 1996 Dec; 50 Suppl 3():831-3. PubMed ID: 9157437
    [No Abstract]   [Full Text] [Related]  

  • 16. Cephalexin (Keflex).
    Med Lett Drugs Ther; 1971 Apr; 13(7):25-6. PubMed ID: 5559657
    [No Abstract]   [Full Text] [Related]  

  • 17. [Refractory respiratory tract infections. 7. Trends in the development of new chemotherapeutic agents for respiratory tract infections. a. Antibiotics].
    Goto H; Shimada K
    Nihon Rinsho; 1987 Mar; 45(3):571-6. PubMed ID: 3298735
    [No Abstract]   [Full Text] [Related]  

  • 18. [Bacterial infections. Progress and new prospects in chemo-antibiotic therapy].
    Olivieri A; Fostini R; Xerri L; Recchia G
    Clin Ter; 1991 Jan; 136(1):53-61. PubMed ID: 1826874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Situation and choice of antimicrobial agents with effects on the so-called "non-specific" respiratory infections].
    Mangiarotti P
    Arch Monaldi Mal Torace; 1989; 44(4-6):743-52. PubMed ID: 2577791
    [No Abstract]   [Full Text] [Related]  

  • 20. [beta-lactam-antibiotics in the treatment of community-acquired respiratory tract infections with penicillin-resistant pneumococci].
    Brauers J; Ewig S; Kresken M
    Pneumologie; 2002 Oct; 56(10):605-9. PubMed ID: 12375222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.